{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:46:27Z","timestamp":1786988787822,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.eprac.2024.10.007","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T07:26:57Z","timestamp":1730273217000},"page":"92-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Complex Web of Interferences With Thyroid Function Tests"],"prefix":"10.1016","volume":"31","author":[{"given":"Huda","family":"Al-Bahadili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Powers Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Markov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8984-3079","authenticated-orcid":false,"given":"Sina","family":"Jasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2024.10.007_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3343\/alm.2019.39.1.3","article-title":"Laboratory testing in thyroid conditions - pitfalls and clinical utility","volume":"39","author":"Soh","year":"2019","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.eprac.2024.10.007_bib2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/thy.2023.0169","article-title":"Thyroid stimulating hormone and thyroid hormones (triiodothyronine and thyroxine): an American thyroid association-commissioned review of current clinical and laboratory status","volume":"33","author":"Van Uytfanghe","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.10.007_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1210\/er.2018-00119","article-title":"Interferences with thyroid function immunoassays: clinical implications and detection algorithm","volume":"39","author":"Favresse","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eprac.2024.10.007_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2019.08.012","article-title":"Best practices in mitigating the risk of biotin interference with laboratory testing","volume":"74","author":"Bowen","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.eprac.2024.10.007_bib5","first-page":"130","article-title":"Significant interference of biotin in thyroid function tests using beckman analyzer: how to identify such interferences?","volume":"53","author":"McBride","year":"2023","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.eprac.2024.10.007_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4158\/EP171761.RA","article-title":"Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks","volume":"23","author":"Samarasinghe","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2024.10.007_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13044-021-00108-y","article-title":"Falsely diagnosed thyrotoxicosis caused by anti-streptavidin antibodies and pre-wash procedures","volume":"14","author":"Ishikawa","year":"2021","journal-title":"Thyroid Res"},{"key":"10.1016\/j.eprac.2024.10.007_bib8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.5603\/EP.a2020.0079","article-title":"Laboratory interference in the thyroid function test","volume":"71","author":"Paczkowska","year":"2020","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.eprac.2024.10.007_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13256-023-04002-z","article-title":"Biotin induced biochemical hyperthyroidism: a case report and review of the literature","volume":"17","author":"James","year":"2023","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.eprac.2024.10.007_bib10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1515\/cclm-2020-0214","article-title":"Biotin interference: evaluation of a new generation of electrochemiluminescent immunoassays for high-sensitive troponin T and thyroid-stimulating hormone testing","volume":"58","author":"Mzougui","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.eprac.2024.10.007_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.acc.2022.03.005","article-title":"Immunoassay design and biotin interference","volume":"109","author":"Dasgupta","year":"2022","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.eprac.2024.10.007_bib12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1089\/thy.2020.0866","article-title":"Biotin interference in assays for thyroid hormones, thyrotropin and thyroglobulin","volume":"31","author":"Ylli","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.10.007_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1517\/17425255.2016.1136288","article-title":"Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis","volume":"12","author":"Peyro Saint Paul","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.eprac.2024.10.007_bib14","first-page":"319","article-title":"Pseudo-hyperthyroidism: biotin interference in a case with renal failure","volume":"17","author":"Demiral","year":"2021","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clinbiochem.2021.10.012","article-title":"The prevalence of elevated biotin in patient cohorts presenting for routine endocrinology, sepsis, and infectious disease testing","volume":"99","author":"Rodrigo","year":"2022","journal-title":"Clin Biochem"},{"key":"10.1016\/j.eprac.2024.10.007_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinbiochem.2018.07.004","article-title":"Prevalence of\u00a0biotin supplement usage in outpatients and plasma biotin concentrations in\u00a0patients presenting to the emergency department","volume":"60","author":"Katzman","year":"2018","journal-title":"Clin Biochem"},{"key":"10.1016\/j.eprac.2024.10.007_bib17","article-title":"Assessment of biotin interference in thyroid function tests","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.eprac.2024.10.007_bib18","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.10.007_bib19","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2024.240122","article-title":"Pseudo elevation of TSH and ACTH caused by heterophilic antibodies: a case report and literature review","volume":"70","author":"Sun","year":"2024","journal-title":"Clin Lab"},{"key":"10.1016\/j.eprac.2024.10.007_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2020.11.018","article-title":"Heterophilic antibody interference with TSH measurement on different immunoassay platforms","volume":"512","author":"Cheng","year":"2021","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.eprac.2024.10.007_bib21","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1515\/cclm-2022-0131","article-title":"Clearance of macro-TSH from the circulation is slower than TSH","volume":"60","author":"Yamada","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.eprac.2024.10.007_bib22","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1089\/thy.2017.0624","article-title":"Current thyrotropin immunoassays recognize macro-thyrotropin leading to hyperthyrotropinemia in females of reproductive age","volume":"28","author":"Hattori","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.10.007_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-15-0883","article-title":"Variability in the detection of macro TSH in different immunoassay systems","volume":"174","author":"Hattori","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib24","first-page":"93","article-title":"Macro-TSH: a diagnostic challenge","volume":"10","author":"Larsen","year":"2021","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.eprac.2024.10.007_bib25","article-title":"A\u00a0Case of macro-TSH masquerading as subclinical hypothyroidism","volume":"14","author":"D\u2019Arcy","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.eprac.2024.10.007_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/thy.2022.0457","article-title":"Prevalence and pathogenesis of macro-thyrotropin in neonates: analysis of umbilical cord blood from 939 neonates and their mothers","volume":"33","author":"Hattori","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.10.007_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0004563213476271","article-title":"An immunoglobulin G complexed form of thyroid-stimulating hormone (macro thyroid-stimulating hormone) is a cause of elevated serum thyroid-stimulating hormone concentration","volume":"50","author":"Mills","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.eprac.2024.10.007_bib28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.5858\/arpa.2012-0270-CR","article-title":"Interference from anti-streptavidin antibody","volume":"137","author":"Rulander","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.eprac.2024.10.007_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clinbiochem.2021.01.013","article-title":"Interference of anti-streptavidin antibodies: more common than we thought? In relation to six confirmed cases","volume":"90","author":"Ricci","year":"2021","journal-title":"Clin Biochem"},{"key":"10.1016\/j.eprac.2024.10.007_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00365513.2020.1858493","article-title":"Endogenous anti-streptavidin antibodies causing erroneous laboratory results more common than anticipated","volume":"81","author":"Dahll","year":"2021","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.eprac.2024.10.007_bib31","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1515\/cclm-2019-1064","article-title":"Interference of anti-streptavidin antibodies in immunoassays: a very rare phenomenon or a more common finding?","volume":"58","author":"Verougstraete","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.eprac.2024.10.007_bib32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1089\/thy.2017.0673","article-title":"Apparent hyperthyroidism caused by biotin-like interference from IgM anti-streptavidin antibodies","volume":"28","author":"Lam","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.10.007_bib33","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1515\/cclm-2023-1344","article-title":"Falsely elevated T due to interference of anti-T autoantibodies: a case report","volume":"62","author":"Jin","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.eprac.2024.10.007_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2265.1994.tb02558.x","article-title":"Prevalence of thyroid hormone autoantibodies in healthy subjects","volume":"41","author":"Sakata","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24124","article-title":"High prevalence of thyroid hormone autoantibody and low rate of thyroid hormone detection interference","volume":"36","author":"Ni","year":"2022","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.eprac.2024.10.007_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1210\/clinem\/dgaa686","article-title":"Evaluation and treatment of amiodarone-induced thyroid disorders","volume":"106","author":"Ylli","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.10.007_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-14-0267","article-title":"The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type","volume":"171","author":"Tomisti","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF03348825","article-title":"Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study","volume":"16","author":"Lombardi","year":"1993","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.eprac.2024.10.007_bib39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.eprac.2024.10.007_bib40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2001.01381.x","article-title":"Association between lithium use and thyrotoxicosis caused by silent thyroiditis","volume":"55","author":"Miller","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.beem.2009.06.002","article-title":"Lithium and thyroid","volume":"23","author":"Lazarus","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.10.007_bib42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4158\/EP.14.5.618","article-title":"Tyrosine kinase inhibitors and the thyroid as both an unintended and an intended target","volume":"14","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2024.10.007_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ecl.2021.12.006","article-title":"Thyroid dysfunction from treatments for solid organ cancers","volume":"51","author":"Kotwal","year":"2022","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.eprac.2024.10.007_bib44","article-title":"Selpercatinib-induced hypothyroidism through off-target inhibition of type 2 iodothyronine deiodinase","volume":"6","author":"Boucai","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.eprac.2024.10.007_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.semcancer.2020.12.008","article-title":"Effects of tyrosine kinase inhibitors on thyroid function and thyroid hormone metabolism","volume":"79","author":"Basolo","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.eprac.2024.10.007_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrclinonc.2009.4","article-title":"Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy","volume":"6","author":"Torino","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.eprac.2024.10.007_bib47","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1210\/jc.2007-0586","article-title":"A\u00a0novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake","volume":"92","author":"Mannavola","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.10.007_bib48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eprac.2024.10.007_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/annonc\/mdw640","article-title":"Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer","volume":"28","author":"Osorio","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eprac.2024.10.007_bib50","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2147\/IJGM.S261433","article-title":"Thyroid dysfunctions due to immune checkpoint inhibitors: a review","volume":"13","author":"El Sabbagh","year":"2020","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.eprac.2024.10.007_bib51","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1089\/thy.2020.0075","article-title":"Immune checkpoint inhibitor-induced thyroiditis is associated with increased intrathyroidal T lymphocyte subpopulations","volume":"30","author":"Kotwal","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.10.007_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43266-9","article-title":"The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: a meta-analysis","volume":"13","author":"Amirabadizadeh","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.eprac.2024.10.007_bib53","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1210\/jc.2018-00359","article-title":"Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features","volume":"103","author":"Pariani","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.10.007_bib54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/jc.2013-2201","article-title":"Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis","volume":"99","author":"Daniels","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.10.007_bib55","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.beem.2009.08.003","article-title":"Drugs that suppress TSH or cause central hypothyroidism","volume":"23","author":"Haugen","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.10.007_bib56","first-page":"95","article-title":"The role of glucocorticoids in the regulation of thyrotropin","volume":"121","author":"Brabant","year":"1989","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/eje.0.1330189","article-title":"Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas","volume":"133","author":"Colao","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/00365528609087435","article-title":"The effect of SMS 201-995, a long-acting somatostatin analogue, on anterior pituitary function in healthy male volunteers","volume":"119","author":"Lightman","year":"1986","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.eprac.2024.10.007_bib59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3816\/CLM.2003.n.006","article-title":"Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma","volume":"3","author":"Sherman","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.eprac.2024.10.007_bib60","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.2147\/CMAR.S224791","article-title":"Managing ipilimumab-induced hypophysitis: challenges and current therapeutic strategies","volume":"12","author":"Tsoli","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.eprac.2024.10.007_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.607446","article-title":"L-T4 therapy in the presence of pharmacological interferents","volume":"11","author":"Benvenga","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib62","series-title":"Thyroid Diseases\u202f: Pathogenesis, Diagnosis, and Treatment","first-page":"733","article-title":"Drugs and other substances interfering with thyroid function","author":"Montanelli","year":"2018"},{"key":"10.1016\/j.eprac.2024.10.007_bib63","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2015.09.002","article-title":"Inherited defects of thyroxine-binding proteins","volume":"29","author":"Pappa","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.10.007_bib64","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fendo.2017.00297","article-title":"Clinical, genetic, and protein structural aspects of familial dysalbuminemic hyperthyroxinemia and hypertriiodothyroninemia","volume":"8","author":"Kragh-Hansen","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/00045632231159280","article-title":"Falsely elevated thyroid hormone levels associated with fibrin interference in patients receiving oral anticoagulant therapy","volume":"60","author":"Tokumaru","year":"2023","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.eprac.2024.10.007_bib66","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-14-0864","article-title":"Chronic lymphocytic thyroiditis: could it be influenced by a petrochemical complex? Data from a cytological study in South-Eastern Sicily","volume":"172","author":"Arena","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2024.10.007_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12020-014-0442-4","article-title":"Chemical contamination and the thyroid","volume":"48","author":"Duntas","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2024.10.007_bib68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11154-016-9327-6","article-title":"Thyroid nodules and thyroid autoimmunity in the context of environmental pollution","volume":"16","author":"Benvenga","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.eprac.2024.10.007_bib69","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MED.0000000000000356","article-title":"Is selenium supplementation in autoimmune thyroid diseases justified?","volume":"24","author":"Winther","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.eprac.2024.10.007_bib70","first-page":"89","article-title":"Favorable effects of myo-inositol, selenomethionine or their combination on the hydrogen peroxide-induced oxidative stress of peripheral mononuclear cells from patients with Hashimoto\u2019s thyroiditis: preliminary in vitro studies","volume":"21","author":"Benvenga","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.eprac.2024.10.007_bib71","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9343(03)00399-1","article-title":"Successive thyroid storms treated with L-carnitine and low doses of methimazole","volume":"115","author":"Benvenga","year":"2003","journal-title":"Am J Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24007997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24007997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T21:01:55Z","timestamp":1736283715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24007997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1530891X24007997"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.10.007","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Complex Web of Interferences With Thyroid Function Tests","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}